Ann Surg

1. ANDO K, Hamabe A, Nakamura Y, Watanabe J, et al
   Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study.
   Ann Surg. 2026;283:13-21.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. VALDES N
   ASO Author Reflections: Can Targeted Nutrition Level the Playing Field? Reflections on Preoperative Support for Malnourished Colorectal Cancer Patients in ERAS.
   Ann Surg Oncol. 2025 Dec 11. doi: 10.1245/s10434-025-18832.
   

   >> Share

   
   
3. ZHENG X, Pinheiro LC, Tehranifar P, Phillips E, et al
   Short-and Long-term Patient Outcomes in Hospitals Primarily Serving Patients with Colorectal Cancer from High-Poverty Areas-An Observational Cohort Study.
   Ann Surg Oncol. 2025 Dec 6. doi: 10.1245/s10434-025-18816.
   

   >> Share

   
   
4. SASSUN R, Sileo A, Ng JC, Mari G, et al
   Low Versus High Ligation of Inferior Mesenteric Artery in Rectal and Sigmoid Cancers: A Systematic Review, Meta-analysis, and Trial Sequential Analysis of Randomized Controlled Trials.
   Ann Surg Oncol. 2026;33:210-219.
   

   >> Share

   
   
5. YOHANATHAN L, Baker T
   Transplant Oncology-A New Frontier in Liver Cancer Care.
   Ann Surg Oncol. 2026;33:561-567.
   

   >> Share

   
   
6. DE ROSE AM, Panettieri E, Lendoire M, Nakao Y, et al
   Short- and Long-Term Outcomes After Hepatectomy in Patients Receiving Triplet Versus Doublet Preoperative Chemotherapy for Colorectal Liver Metastases.
   Ann Surg Oncol. 2026;33:599-608.
   

   >> Share

   
   
7. SEKHON INDERJIT SINGH HK, Lord A, Pawa N, Brown G, et al
   The Prognostic Impact of Imaging Detected Tumor Deposits in Rectal Cancer: A Systematic Review and Meta-analysis.
   Ann Surg Oncol. 2026;33:199-209.
   

   >> Share

   
   
8. CYR-CRONIER J, Lebel-Guay F, Sideris L, Gervais MK, et al
   Radiologic and Pathologic Response as Predictors of Survival in Patients with Colorectal Peritoneal Metastases Undergoing Neoadjuvant Chemotherapy Followed by CRS-HIPEC: A Retrospective Study.
   Ann Surg Oncol. 2026;33:426-434.
   

   >> Share

   
   

   
   BMC Cancer

9. ZHANG Y, Zhang W, Li T, Hao E, et al
   A Multi-PTM omics atlas uncovers novel aging regulators in colorectal cancer.
   BMC Cancer. 2025 Dec 12. doi: 10.1186/s12885-025-15274.
   

   >> Share

   
   
10. AZARSHIN SZ, Malmir M, Sajjadi SF, Behmanesh M, et al
    CXCR3 gene as a therapeutic target in colorectal cancer.
    BMC Cancer. 2025 Dec 12. doi: 10.1186/s12885-025-15409.
    

    >> Share

    
    

    
    BMC Gastroenterol

11. FUJINO S, Miyoshi N, Hayashi R, Kato S, et al
    Behavioral changes and delayed colorectal cancer diagnosis during COVID-19: a real-world survey analysis.
    BMC Gastroenterol. 2025 Dec 13. doi: 10.1186/s12876-025-04550.
    

    >> Share

    
    

    
    Br J Cancer

12. MATSUBARA Y, Bando H, Nakamura Y, Misumi T, et al
    Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy.
    Br J Cancer. 2025 Dec 8. doi: 10.1038/s41416-025-03270.
    

    >> Share

    
    
13. DENG JW, Zhou YL, Zhang YX, Zhou CB, et al
    The relationship between gut microbiota, lifestyle habits, and early-onset colorectal cancer: shedding light on early prediction.
    Br J Cancer. 2025 Dec 9. doi: 10.1038/s41416-025-03277.
    

    >> Share

    
    

    
    Cancer

14. FANG J, Zheng Z, Chen T, Liu J, et al
    Efficacy and safety of PD-L1 blockade envafolimab as neoadjuvant treatment in mismatch repair-deficient, locally advanced colorectal cancer: An open-label, single-arm study.
    Cancer. 2025;131:e70203.
    

    >> Share

    
    

    
    Cancer Lett

15. CHEN Z, Liang Z, Cai T, Yang X, et al
    ANGPTL3 promotes colorectal carcinoma progression and metastasis through regulating COL1A2 transcription via interacting with integrin alphaVbeta3.
    Cancer Lett. 2026;638:218150.
    

    >> Share

    
    

    
    Dis Colon Rectum

16. JI H, Xu M, Hu Y, Yan B, et al
    Preoperative Identification of Lymph Node Metastasis in Colorectal Cancer Using Noninvasive ctDNA Methylation Signatures: Results from a Prospective Study.
    Dis Colon Rectum. 2025 Dec 11. doi: 10.1097/DCR.0000000000004089.
    

    >> Share

    
    
17. ATULURU P, Kwendakwema CN, Bell-Brown A, Hopkins T, et al
    Patient Perspectives on Barriers and Facilitators to 1-year Surveillance Colonoscopy Completion in Survivors of Colorectal Cancer: A Multi-Method Analysis.
    Dis Colon Rectum. 2025 Dec 10. doi: 10.1097/DCR.0000000000004067.
    

    >> Share

    
    
18. REDDAVID R, Elmore U, Azzolina D, Moro J, et al
    Rectal Cancer in the Elderly: To Operate or Not to Operate? A Nationwide Retrospective Study of the Italian Society of Surgical Oncology-Colorectal Cancer Network Collaborative Group.
    Dis Colon Rectum. 2025 Dec 8. doi: 10.1097/DCR.0000000000003961.
    

    >> Share

    
    
19. LEUNG SW, Rehman N, Alatout MH, Etzioni DA, et al
    A Mutation-Specific Decision Model for Segmental versus Total Abdominal Colectomy in Hereditary Nonpolyposis Colorectal Cancer.
    Dis Colon Rectum. 2025 Dec 8. doi: 10.1097/DCR.0000000000004042.
    

    >> Share

    
    

    
    Eur J Surg Oncol

20. CICERONE O, Corallo S, De Silvestri A, Serra F, et al
    Anti-EGFR plus chemotherapy vs. chemotherapy alone in RAS wild-type colorectal liver metastases: A meta-analysis of survival outcomes in resectable and unresectable settings.
    Eur J Surg Oncol. 2026;52:111155.
    

    >> Share

    
    
21. ABERLE MR, Ligthart MAP, West MA, Rensen SS, et al
    Gain of visceral adipose tissue rather than low skeletal muscle mass is associated with overall survival in patients with colorectal liver metastases; results from the NewEPOC study.
    Eur J Surg Oncol. 2026;52:111179.
    

    >> Share

    
    
22. BROWN KGM, Ng KS, Solomon MJ, Vu J, et al
    Preoperative predictors of priority outcomes of pelvic exenteration for locally recurrent rectal cancer: Results of the mixed-methods EviSurg study.
    Eur J Surg Oncol. 2026;52:111183.
    

    >> Share

    
    

    
    Gastroenterology

23. MANNUCCI A, Balaguer F, Yamada Y, Nagasaka T, et al
    An Exosome-Based Liquid Biopsy for the Detection of Early-Onset Colorectal Cancer: The ENCODER Multicenter Study.
    Gastroenterology. 2025 Dec 9:S0016-5085(25)05897.
    

    >> Share

    
    

    
    Gut

24. CHEN Y, Padilla Aponte J, Wang K, Du M, et al
    Comparative risk of high-risk neoplasia after polypectomy among individuals aged below 50 years versus 50 years and older.
    Gut. 2025;75:72-80.
    

    >> Share

    
    

    
    Int J Cancer

25. ORANGE ST, Dodd E, Nath S, Bowden H, et al
    Exercise serum promotes DNA damage repair and remodels gene expression in colon cancer cells.
    Int J Cancer. 2025 Dec 12. doi: 10.1002/ijc.70271.
    

    >> Share

    
    

    
    Int J Colorectal Dis

26. CHEN JJ, Li ZL, Yang Y, Wang ZJ, et al
    Impact of age on short-term outcomes and oncologic prognosis after radical surgery for colorectal cancer over 60.
    Int J Colorectal Dis. 2025;40:247.
    

    >> Share

    
    

    
    Int J Oncol

27. XIONG B, Ma L, Hu X, Zhang C, et al
    [Retracted] Characterization of side population cells isolated from the colon cancer cell line SW480.
    Int J Oncol. 2026;68:22.
    

    >> Share

    
    

    
    J Clin Oncol

28. RATAIN MJ, Fojo AT
    Opportunities for Harmonization of US Food and Drug Administration Regulatory Decisions Exemplified by the Traditional Approval of Sotorasib and Panitumumab for Colorectal Cancer.
    J Clin Oncol. 2025 Dec 5:JCO2501607. doi: 10.1200/JCO-25-01607.
    

    >> Share

    
    

    
    J Natl Cancer Inst

29. HAAS JS, Todd KW, Mclerran D, Tiro JA, et al
    Gaps in care across the cancer screening continuum for cervical, colorectal and lung cancer.
    J Natl Cancer Inst. 2025 Sep 10:djaf248. doi: 10.1093.
    

    >> Share

    
    
30. BOIGE V, Menoret E, Le Teuff G, Boyer JC, et al
    A predictive model for life-threatening fluoropyrimidine toxicity based on DPYD sequencing in colorectal cancer.
    J Natl Cancer Inst. 2025 Dec 12:djaf357. doi: 10.1093.
    

    >> Share

    
    
31. YU Z
    RE: a prediction model for metachronous colorectal cancer: development and validation.
    J Natl Cancer Inst. 2025 Dec 13:djaf351. doi: 10.1093.
    

    >> Share

    
    

    
    J Surg Oncol

32. FENG J
    Comment on "Noncolorectal Cancer-Related Deaths in Patients With Early-Onset Colorectal Cancer: A Population-Based Study".
    J Surg Oncol. 2025 Dec 9. doi: 10.1002/jso.70160.
    

    >> Share

    
    
33. SANLI AN, Tekcan Sanli DE
    Comment on "A SEER-Based Analysis of Survival Predictors in Stage I Colorectal Cancer".
    J Surg Oncol. 2025 Dec 7. doi: 10.1002/jso.70156.
    

    >> Share

    
    

    
    Oncology

34. FORMICA V, Morelli C, Rofei M, Sansone M, et al
    Clinicomics for predicting HER2 expression in metastatic colorectal cancer: a multicenter machine learning analysis on real-world data.
    Oncology. 2025 Dec 4:1-24. doi: 10.1159/000549661.
    

    >> Share

    
    

    
    PLoS One

35. AKARAPREDEE N, Atasilp C, Sukasem C, Jinda P, et al
    Impacts of polymorphisms in drug-metabolizing enzyme and transporter genes on irinotecan toxicity and efficacy in Thai colorectal cancer patients.
    PLoS One. 2025;20:e0338442.
    

    >> Share

    
    
36. SUN Y, Zhu G, Lian D, Amin B, et al
    Multi-dimensional analysis of the global burden of colorectal cancer disease from 1990 to 2021 and prediction of future trends: A comprehensive study based on the GBD database.
    PLoS One. 2025;20:e0337216.
    

    >> Share

    
    
37. HOBSON LM, Martin RM, Smith-Byrne K, Davey Smith G, et al
    A protocol for using human genetic data to identify circulating protein level changes that are the causal consequence of cancer processes.
    PLoS One. 2025;20:e0312970.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share